Muthumani K - Search Results

1

HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro.

Muthumani K, Hwang DS, Choo AY, Mayilvahanan S, Dayes NS, Thieu KP, Weiner DB. Muthumani K, et al. Int Immunol. 2005 Feb;17(2):103-16. doi: 10.1093/intimm/dxh190. Epub 2004 Dec 20. Int Immunol. 2005. PMID: 15611322

2

HIV-1 viral protein R compromises cellular immune function in vivo.

Ayyavoo V, Muthumani K, Kudchodkar S, Zhang D, Ramanathan P, Dayes NS, Kim JJ, Sin JI, Montaner LJ, Weiner DB. Ayyavoo V, et al. Among authors: muthumani k. Int Immunol. 2002 Jan;14(1):13-22. doi: 10.1093/intimm/14.1.13. Int Immunol. 2002. PMID: 11751747

3

HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells.

Muthumani K, Hwang DS, Desai BM, Zhang D, Dayes N, Green DR, Weiner DB. Muthumani K, et al. J Biol Chem. 2002 Oct 4;277(40):37820-31. doi: 10.1074/jbc.M205313200. Epub 2002 Jul 2. J Biol Chem. 2002. PMID: 12095993 Free article.

4

Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines.

Muthumani K, Zhang D, Hwang DS, Kudchodkar S, Dayes NS, Desai BM, Malik AS, Yang JS, Chattergoon MA, Maguire HC Jr, Weiner DB. Muthumani K, et al. Oncogene. 2002 Jul 11;21(30):4613-25. doi: 10.1038/sj.onc.1205549. Oncogene. 2002. PMID: 12096338

5

The HIV-1 accessory gene vpr can inhibit antigen-specific immune function.

Muthumani K, Hwang DS, Dayes NS, Kim JJ, Weiner DB. Muthumani K, et al. DNA Cell Biol. 2002 Sep;21(9):689-95. doi: 10.1089/104454902760330237. DNA Cell Biol. 2002. PMID: 12396612

6

Mechanism of HIV-1 viral protein R-induced apoptosis.

Muthumani K, Choo AY, Hwang DS, Chattergoon MA, Dayes NN, Zhang D, Lee MD, Duvvuri U, Weiner DB. Muthumani K, et al. Biochem Biophys Res Commun. 2003 May 9;304(3):583-92. doi: 10.1016/s0006-291x(03)00631-4. Biochem Biophys Res Commun. 2003. PMID: 12729593 Review.

7

Suppression of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor.

Muthumani K, Wadsworth SA, Dayes NS, Hwang DS, Choo AY, Abeysinghe HR, Siekierka JJ, Weiner DB. Muthumani K, et al. AIDS. 2004 Mar 26;18(5):739-48. doi: 10.1097/00002030-200403260-00004. AIDS. 2004. PMID: 15075508

8

HIV-1 Vpr and anti-inflammatory activity.

Muthumani K, Desai BM, Hwang DS, Choo AY, Laddy DJ, Thieu KP, Rao RG, Weiner DB. Muthumani K, et al. DNA Cell Biol. 2004 Apr;23(4):239-47. doi: 10.1089/104454904773819824. DNA Cell Biol. 2004. PMID: 15142381 Review.

9

HIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activation.

Muthumani K, Choo AY, Hwang DS, Premkumar A, Dayes NS, Harris C, Green DR, Wadsworth SA, Siekierka JJ, Weiner DB. Muthumani K, et al. Blood. 2005 Sep 15;106(6):2059-68. doi: 10.1182/blood-2005-03-0932. Epub 2005 May 31. Blood. 2005. PMID: 15928037 Free PMC article.

10

HIV-1 Viral protein-r (Vpr) protects against lethal superantigen challenge while maintaining homeostatic T cell levels in vivo.

Muthumani K, Choo AY, Hwang DS, Dayes NS, Chattergoon M, Mayilvahanan S, Thieu KP, Buckley PT, Emmanuel J, Premkumar A, Weiner DB. Muthumani K, et al. Mol Ther. 2005 Nov;12(5):910-21. doi: 10.1016/j.ymthe.2005.05.009. Epub 2005 Jul 11. Mol Ther. 2005. PMID: 16006193 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page